First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer

被引:17
作者
Wegen, Simone [1 ]
Roth, Katrin Sabine [2 ,3 ]
Weindler, Jasmin [2 ,3 ]
Claus, Karina [1 ]
Linde, Philipp [1 ]
Trommer, Maike [1 ]
Akuamoa-Boateng, Dennis [1 ]
van Heek, Lutz [2 ,3 ]
Baues, Christian [1 ]
Schoemig-Markiefka, Birgid [4 ]
Schomaecker, Klaus [2 ,3 ]
Fischer, Thomas [2 ,3 ]
Drzezga, Alexander [2 ,3 ,5 ,6 ]
Kobe, Carsten [2 ,3 ]
Koehler, Christhardt [7 ]
Marnitz, Simone [1 ]
机构
[1] Univ Hosp Cologne, Dept Radiat Oncol Cyberknife & Radiotherapy, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Fac Med, Dept Nucl Med, Cologne, Germany
[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[4] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[5] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany
[6] Forschungszentrum Julich, Inst Neurosci & Med INM 2, Mol Org Brain, Julich, Germany
[7] Asklepios Hosp Grp, Dept Special Operat & Oncol Gynecol, Asklepios Clin Hamburg Altona, Hamburg, Germany
关键词
FAPI PET; cervical cancer; FDG PET; surgical lymph node staging; CHEMORADIATION; METASTASES;
D O I
10.1097/RLU.0000000000004505
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionIn several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [Ga-68]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [Ga-68]Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [F-18]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation.MethodsSeven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [Ga-68]Ga-FAPI-46- and [F-18]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP.ResultsAll 7 patients had focal uptake above background in their tumor lesions in [Ga-68]Ga-FAPI-46 PET/CT. [Ga-68]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBRmax values using liver were 32.02 and 5.15 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Median TBRmax using blood pool was 18.45 versus 6.85 for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBRmax was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [Ga-68]Ga-FAPI-46 PET/CT and [F-18]F-FDG PET/CT, respectively. Overall, [Ga-68]Ga-FAPI-46 PET/CT detected more lesions compared with [F-18]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [F-18]F-FDG PET/CT and [Ga-68]Ga-FAPI-46 PET/CT, respectively.Conclusion[Ga-68]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [Ga-68]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 50 条
  • [21] IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET/CT
    Luo, Yaping
    Pan, Qingqing
    Zhang, Wen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (12) : 2625 - 2626
  • [22] [18F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review
    Hotton, Judicael
    Beddok, Arnaud
    Moubtakir, Abdenasser
    Papathanassiou, Dimitri
    Morland, David
    DIAGNOSTICS, 2025, 15 (01)
  • [23] [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial
    Zanoni, Lucia
    Fortunati, Emilia
    Cuzzani, Giulia
    Malizia, Claudio
    Lodi, Filippo
    Cabitza, Veronica Serena
    Brusa, Irene
    Emiliani, Stefano
    Assenza, Marta
    Antonacci, Filippo
    Giunchi, Francesca
    Degiovanni, Alessio
    Ferrari, Marco
    Natali, Filippo
    Galasso, Thomas
    Bandelli, Gian Piero
    Civollani, Simona
    Candoli, Piero
    D'Errico, Antonietta
    Solli, Piergiorgio
    Fanti, Stefano
    Nanni, Cristina
    PHARMACEUTICALS, 2024, 17 (11)
  • [24] The role of [18F]FDG PET/CT for gastric cancer management
    Salmanoglu, Ebru
    NUCLEAR MEDICINE REVIEW, 2021, 24 (02) : 99 - 103
  • [25] The Added Value of 68Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with 18F-FDG-Negative Findings
    Gu, Bingxin
    Xu, Xiaoping
    Zhang, Ji
    Ou, Xiaomin
    Xia, Zuguang
    Guan, Qing
    Hu, Silong
    Yang, Zhongyi
    Song, Shaoli
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) : 875 - 881
  • [26] Metastatic prostate adenocarcinoma with neuroendocrine differentiation on 18F-FDG PET/CT, 68Ga-PSMA PET/CT and 68Ga-DOTA TATE PET/CT with injected ultra-low-activity
    Zhang, Y.
    He, Y.
    Yu, H.
    Shi, H.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2022, 46 (5-6): : 224 - 226
  • [27] 18F-FDG PET/CT in the Staging and Management of Breast Cancer
    Garcia, J. R.
    Perez, Cristina
    Bassa, Pere
    Capdevila, Laia
    Ramos, Francisco
    Valenti, Vicens
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (03) : 191 - 192
  • [28] Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients
    Giesel, Frederik L.
    Kratochwil, Clemens
    Schlittenhardt, Joel
    Dendl, Katharina
    Eiber, Matthias
    Staudinger, Fabian
    Kessler, Lukas
    Fendler, Wolfgang P.
    Lindner, Thomas
    Koerber, Stefan A.
    Cardinale, Jens
    Sennung, David
    Roehrich, Manuel
    Debus, Juergen
    Sathekge, Mike
    Haberkorn, Uwe
    Calais, Jeremie
    Serfling, Sebastian
    Buck, Andreas L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (13) : 4377 - 4385
  • [29] 18F-FDG PET/MRI Primary Staging of Cervical Cancer: A Pilot Study with PET/CT Comparison
    Nguyen, Nghi C.
    Beriwal, Sushil
    Moon, Chan-Hong
    Furlan, Alessandro
    Mountz, James M.
    Rangaswamy, Balasubramanya
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2020, 48 (04) : 331 - 335
  • [30] Gallbladder cancer staging with 18F-FDG PET-CT
    Ramos-Font, C.
    Santiago Chinchilla, A.
    Rodriguez-Fernandez, A.
    Rebollo Aguirre, A. C.
    Gomez Rio, M.
    Llamas Elvira, J. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2009, 28 (02): : 74 - 77